Can a dog be killed with isoniazid? - briefly
Yes, dogs can be killed by isoniazid if they ingest a large enough amount. This antibiotic is highly toxic to dogs and can cause severe liver damage leading to death if not treated promptly.
Can a dog be killed with isoniazid? - in detail
Isoniazid, commonly known as INH, is an antitubercular drug primarily used in the treatment of tuberculosis (TB) in humans and occasionally in animals. The question of whether a dog can be killed with isoniazid is complex and requires a nuanced understanding of pharmacokinetics, toxicology, and species-specific sensitivities.
Isoniazid is generally well-tolerated in dogs at therapeutic doses, but it has a narrow therapeutic index, meaning the difference between an effective dose and a toxic dose is small. The primary concern with isoniazid use in dogs is the potential for hepatotoxicity, or liver damage. Dogs are more susceptible to this adverse effect compared to humans due to differences in drug metabolism.
In dogs, isoniazid is primarily metabolized by the liver enzyme N-acetyltransferase 2 (NAT2). Variations in NAT2 activity can lead to either rapid or slow metabolism of the drug. Dogs with slow NAT2 activity are at a higher risk for toxicity because they accumulate higher levels of isoniazid and its active metabolites, which can cause liver damage. Symptoms of hepatotoxicity include lethargy, inappetence, vomiting, diarrhea, and jaundice (yellowing of the skin and eyes).
Acute overdose of isoniazid in dogs can also lead to severe and potentially fatal complications. Signs of acute toxicity may include seizures, ataxia (loss of coordination), coma, and even death due to respiratory depression or cardiac arrest. The LD50 (median lethal dose) for isoniazid in dogs has been estimated to be around 100-200 mg/kg, indicating that relatively small overdoses can be life-threatening.
To mitigate the risks associated with isoniazid use in dogs, veterinarians often recommend close monitoring of liver function through regular blood tests. Additionally, supplementation with pyridoxine (vitamin B6) is commonly prescribed to help prevent or reduce the severity of hepatotoxicity. Pyridoxine acts as a competitive inhibitor of isoniazid's active metabolites, thereby reducing their toxic effects on the liver.
In conclusion, while isoniazid can be safely used in dogs under veterinary supervision and with appropriate monitoring, the potential for severe adverse effects, including death, underscores the importance of careful dosing and individualized treatment plans. Owners should always consult with a veterinarian before administering any medication to their pets.